Targeted Proteomics Analysis of Staphylococcal Superantigenic Toxins in Menstrual Fluid from Women with Menstrual Toxic Shock Syndrome (mTSS)

Menstrual toxic shock syndrome (mTSS) is a rare life-threatening febrile illness that occurs in women using intravaginal menstrual protection. It is caused by toxic shock syndrome toxin 1 (TSST-1) produced by Staphylococcus aureus, triggering a sudden onset of rash and hypotension, subsequently leading to multiple organ failure. Detecting TSST-1 and S. aureus virulence factors in menstrual fluid could accelerate the diagnosis and improve therapeutic management of mTSS. However, menstrual fluid is a highly complex matrix, making detection of bacterial toxins challenging. Here, we present a mass-spectrometry-based proteomics workflow for the targeted, quantitative analysis of four S. aureus superantigenic toxins in menstrual fluids (TSST-1, SEA, SEC, and SED). This method was applied to characterize toxin levels in menstrual fluids collected from patients with mTSS and healthy women. Toxins were detectable in samples from patients with mTSS and one healthy donor at concentrations ranging from 0 to 0.46 µg/mL for TSST-1, and 0 to 1.07 µg/mL for SEC. SEA and SED were never detected in clinical specimens, even though many S. aureus strains were positive for the corresponding genes. The method presented here could be used to explore toxin production in vivo in users of intravaginal devices to improve the diagnosis, understanding, and prevention of mTSS.

[1]  J. Thioulouse,et al.  Vaginal Tampon Colonization by Staphylococcus aureus in Healthy Women , 2020, Applied and Environmental Microbiology.

[2]  C. Davis,et al.  Device-Associated Menstrual Toxic Shock Syndrome , 2020, Clinical Microbiology Reviews.

[3]  P. Vanhems,et al.  Association of characteristics of tampon use with menstrual toxic shock syndrome in France , 2020, EClinicalMedicine.

[4]  J. Thioulouse,et al.  Complex ecological interactions of Staphylococcus aureus in tampons during menstruation , 2018, Scientific Reports.

[5]  Annette Lee,et al.  Analysis of menstrual effluent: diagnostic potential for endometriosis , 2018, Molecular Medicine.

[6]  J. Wiśniewski,et al.  Quantitative Analysis of Human Red Blood Cell Proteome. , 2017, Journal of proteome research.

[7]  M. Jaquinod,et al.  A proteomics assay to detect eight CBRN‐relevant toxins in food , 2017, Proteomics.

[8]  P. François,et al.  The TIR Homologue Lies near Resistance Genes in Staphylococcus aureus, Coupling Modulation of Virulence and Antimicrobial Susceptibility , 2017, PLoS pathogens.

[9]  K. Vaswani,et al.  Applying SWATH Mass Spectrometry to Investigate Human Cervicovaginal Fluid During the Menstrual Cycle1 , 2015, Biology of reproduction.

[10]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[11]  P. Schlievert,et al.  Staphylococcal and Streptococcal Superantigen Exotoxins , 2013, Clinical Microbiology Reviews.

[12]  D. Low Toxic shock syndrome: major advances in pathogenesis, but not treatment. , 2013, Critical care clinics.

[13]  M. Prinz,et al.  Proteomic Analysis of Menstrual Blood* , 2012, Molecular & Cellular Proteomics.

[14]  J. Garin,et al.  Introducing AAA-MS, a rapid and sensitive method for amino acid analysis using isotope dilution and high-resolution mass spectrometry. , 2012, Journal of proteome research.

[15]  Christophe Bruley,et al.  Development of a Protein Standard Absolute Quantification (PSAQ™) assay for the quantification of Staphylococcus aureus enterotoxin A in serum. , 2012, Journal of proteomics.

[16]  Matthias Mann,et al.  Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis. , 2012, Analytical chemistry.

[17]  R. Aebersold,et al.  A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas* , 2011, Molecular & Cellular Proteomics.

[18]  C. Davis,et al.  Staphylococcus aureus Exotoxins Are Present In Vivo in Tampons , 2010, Clinical and Vaccine Immunology.

[19]  J. Garin,et al.  Isotope dilution strategies for absolute quantitative proteomics. , 2009, Journal of proteomics.

[20]  A. Ferguson,et al.  Gram-positive toxic shock syndromes. , 2009, The Lancet. Infectious diseases.

[21]  F. Vandenesch,et al.  Staphylococcus aureus Superantigens Elicit Redundant and Extensive Human Vβ Patterns , 2009, Infection and Immunity.

[22]  F. Vandenesch,et al.  Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[23]  F. Vandenesch,et al.  Isotope-labeled Protein Standards , 2007, Molecular & Cellular Proteomics.

[24]  J. E. Wild,et al.  Prevalence of Toxic Shock Syndrome Toxin 1-Producing Staphylococcus aureus and the Presence of Antibodies to This Superantigen in Menstruating Women , 2005, Journal of Clinical Microbiology.

[25]  R. Novick,et al.  Global repression of exotoxin synthesis by staphylococcal superantigens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Rosten,et al.  Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay , 1987, Journal of clinical microbiology.

[27]  J. Nagel,et al.  Interaction of staphylococcal protein A in enzyme-linked immunosorbent assays for detecting staphylococcal antigens. , 1982, Journal of immunological methods.

[28]  J. Garin,et al.  Production and use of stable isotope-labeled proteins for absolute quantitative proteomics. , 2011, Methods in molecular biology.

[29]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .